THERESA WEBB: Open Payments
NPI 1033652615 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 35 payments from 10 companies in 2025. Trend: 2023 $2,748 · 2024 $1,366 · 2025 $791
Food & beverage: $791
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $210 |
| ABBVIE INC. | 4 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| Neurocrine BioSciences, Inc. | 3 | $82 |
| Supernus Pharmaceuticals, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Lundbeck LLC | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Indivior Inc. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: ARISTADA, REXULTI, VRAYLAR, CAPLYTA, INGREZZA, Qelbree, SUBLOCADE, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
